[Latin Name] Cinnamomun camphcra

[Plant Source] It is extracted from Ginkgo Biloba Leaf.

[Specifications]

1, Ginkgo Biloba Extract 24/6

Total Ginkgo flavone glycosides 24%

Total terpene lactones 6%

2, Ginkgo Biloba Extract 24/6

Total Ginkgo flavone glycosides 24%

Total terpene lactones 6%

Ginkgolic acid 5ppm

3,CP2005

Total Ginkgo flavone glycosides 24%

Quercatin: kaemperol 0.8–1.5

Total terpene lactones 6%

Ginkgolic acid <5ppm

4.Germany Standard

Total Ginkgo Flavone Glycosides 22.0%-27%

Total Terpene Lactones 5.0%-7.0%

Bilobalides 2.6%-3.2%

Ginkgolic acid <1ppm

5.Water-Soluble Ginkgo Biloba Extract 24/6

Water Solubility: 5g Ginkgo Biloba Extract will be dissolved completely in 100g water

Total Ginkgo Flavone Glycosides 24.0%

Total Terpene Lactones 6.0%

Ginkgolic acid <5.0ppm

[Appearance] Light yellow fine powder

[Particle size] 80 Mesh

[Loss on drying] £ 5.0%

[Heavy Metal] £10PPM

[Extract solvents] Ethanol

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Package] Packed in paper-drums and two plastic-bags inside.

[Function]

Expanding blood vessel, resisting insufficient blood and oxygen deficit, increasing blood flow, improving cerebral arteries and distal

blood flow. Promoting cerebral circulation metabolism, improving memory function, resisting depression, resisting lipidic overoxidation,

protecting liver damage.

In clinic, curing high blood pressure, hyperlipoidemia, coronary heart disease, angina pectoris, arterial sclerosis, cerebral embolism,

senile dementia, primary and periodic dropsy, acute drumming in the ears, epicophosis, a variety of body function in disorder, dizziness

and so on.

[https://www.anubhavbiotech.net/ ] Our company vested itself by the name Anubhav Biotech Limited in the year 2008 as Public Limited Company with its headquarters at Kolkata, West Bengal (India). Our company is ventured in the manufacturing and exporting of various biotech products such as Stevia Extract, Steviose Sweet Drop, Stevioside Powder, Psyllium Husk and many more. It is our all-inclusive range of medicinal products with which we have carved such a strong market niche. Our translucent trading, ethical policies and client centric approaches have enabled us to lay a dynamic growth in our organization. With our strong distribution circuitry profile, we are catering to numerous national and international clients.

(See https://nanohour.beckman.illinois.edu/Nanohour/Nanohour.html)

” A Tooth Problem: Biomodification of Dentin Matrices as Novel Strategy for Dental Therapies”

Prof. Ana Bedran-Russo (UIC College of Dentistry)

“It is estimated that in the United States, 350 million dental restorations
(fillings) are placed every year in dental offices. Sixty percent of those restorations
replace existing failed restorative treatments. The primary reason for failure of
dental restorations is secondary caries (decay), indicative of increased permeability
and debonding between tooth and restorative biomaterial. Current dental adhesive
restorative systems rely on the micromechanical retentions of restorations by
infiltrations of hydrophilic and hydrophobic resins into a collagen-rich surface on
dentin. Our laboratory at UIC has focused on understanding the tooth
biochemistry/biomechanics and explored biomimetic approaches for innovative
restorative/regenerative therapies. Specifically the interactions of olygomeric
proanthocyanidins agents (OPC) with dentin matrices to improve mechanical
properties and reduced biodegradation rates. This presentation will provide (1)
overview of challenges in the harsh oral environment (2) limitations of current
dental therapies and (3) mechanisms of interactions of OPC with type I collagen,
proteoglycans and matrix metalloproteinases (MMPs).”